The US Chamber of Commerce and affiliates sought to convince a three-judge appellate panel that it can challenge a Biden-era drug price program after a lower court ruled it lacked proper venue and associational standing to bring the suit.
“What the district court is concerned about here is, though, that basically this was a forum shopping,” Circuit Judge
At issue before the US Court of Appeals for the Sixth Circuit is whether the US Chamber can challenge the US government’s Medicare Drug Price Negotiation Program, a plan created under ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.